drugcoverage - Vectibix - Amgen Canada Inc.

Medication Brand Name:

Vectibix

Active Ingredient:

panitumumab

DIN(s) in Canada:

02308487

francais

Manufacturer/Distributor:

Amgen Canada Inc.

DrugCoverage Category:

Cancer

See Also:

Vectibix has been approved for funding in British Columbia, Ontario and Alberta (according to eligibility criteria) and is currently under review for funding in the other provinces, territories and through the federal drug plans. Vectibix is an eligible benefit through some private insurance plans. See summary below. More detailed information (including reimbursement criteria, guidelines, claim forms) can be accessed by clicking HERE. Amgen Canada's VICTORY Program 1-888-706-4717 provides reimbursement information and assistance 24 hours a day, 7 days per week.

Coverage/Reimbursement by Private Insurance Plans in Canada

Vectibix is an eligible benefit through some private insurance plans. Some plans may require prior / special authorization before granting coverage. More detailed information (including reimbursement criteria, guidelines, claim forms) can be accessed by clicking HERE. Amgen Canada's VICTORY Program 1-888-706-4717 provides reimbursement information and assistance 24 hours a day, 7 days per week.

Coverage/Reimbursement by Canadian Provincial/Territorial Programs
Province	Coverage	Program / Eligibility Criteria
AB		Vectibix is covered according to eligibility criteria by the Alberta Cancer Board.
BC		Vectibix is covered according to eligibility criteria through the BC Cancer Agency Benefit Drug List.
MB		Vectibix is under review by the provincial funding agency.
NB		Vectibix is under review by the provincial funding agency.
NL		Vectibix is under review by the provincial funding agency.
NT		Vectibix is under review by the territorial funding agency.
NS		Vectibix is under review by the provincial funding agency.
NU		Vectibix is under review by the territorial funding agency.
ON		Vectibix is covered is covered according to eligibility criteria through the MOHTLC/Cancer Care Ontario New Drug Funding Program.
PE		Vectibix is under review by the provincial funding agency.
QC		Vectibix may be covered through RAMQ's Exception Patient Measure
SK		Vectibix is currently under review by the provincial funding agency.
YT		Vectibix is under review by the territorial funding agency.

Coverage/Reimbursement by Canadian Federal Plans
Plan	Coverage	Program / Eligibility Criteria
Public Services Health Care Plan		Vectibix may be covered by the PSHCP
Non-Insured Health Benefits Program		Vectibix is currently under review by the NIHB
Veterans Affairs Canada		Vectibix is currently under review by Veterans Affairs Canada
Canadian Forces Health Services		Vectibix is currently under review by the Canadian Forces Health Services
Interim Federal Health Program		Vectibix is currently under review by the Interim Federal Health Program